HER2 Heterogeneity in Gastric Cancer: A Comparative Study, Using Two Commercial Antibodies

BACKGROUND: Although amplification of the gene encoding human epidermal growth factor receptor 2 (HER2) is used as an indicator for response to trastuzumab, the reported response rate is low, and few patients with gastric cancer (GC) benefit from this individualized therapy. The aim of this study wa...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Oncol
Glavni autori: Satala, Catalin Bogdan, Jung, Ioan, Stefan-van Staden, Raluca Ioana, Kovacs, Zsolt, Molnar, Calin, Bara, Tivadar, Fulop, Zsolt Zoltan, Gurzu, Simona
Format: Artigo
Jezik:Inglês
Izdano: Hindawi 2020
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7596543/
https://ncbi.nlm.nih.gov/pubmed/33144857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8860174
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items